Abstract
A patient with structural valve degeneration of an aortic bioprosthesis with stenosis stage 3 underwent valve-in-valve transcatheter aortic valve replacement (TAVR) at 29 weeks with improvement. This is the first reported TAVR in the third trimester. TAVR may be an alternative to preterm delivery in cases of symptomatic aortic stenosis.
Original language | English (US) |
---|---|
Article number | 102104 |
Journal | JACC: Case Reports |
Volume | 27 |
DOIs | |
State | Published - Dec 6 2023 |
Bibliographical note
Publisher Copyright:© 2023 The Authors
Keywords
- aortic stenosis
- bicuspid aortic valve
- pregnancy
- valve replacement
PubMed: MeSH publication types
- Case Reports